Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients
Clinical trial NCT05338723 · COMPLETED
Trial details
- NCT number
- NCT05338723
- Sponsor
- Tanta University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2023-09-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.